GlassScriptPhysician profile
Dean C Taylor
NPI 1104841717
$140,084.96
in general payments reported to CMS, 2019-2025
10 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $21K · 2021: $24K · 2022: $28K · 2023: $28K · 2024: $18K · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $45K · Food and Beverage: $721 · Entertainment: $72.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $45,033.20 |
| Food and Beverage | $721.07 |
| Entertainment | $72.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $139,006.22 | 2019-2024 | Mitek Cruciate+ |
| Tricoast Surgical Solutions LLC | $331.88 | 2024-2025 | |
| Djo, LLC | $191.66 | 2019-2023 | Donjoy, Aircast |
| Miach Orthopaedics, INC. | $175.37 | 2021 | |
| Arthrex, INC. | $146.88 | 2023-2025 | |
| Depuy Synthes Sales INC. | $81.42 | 2019 | |
| Vericel Corporation | $72.37 | 2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $53.86 | 2024 | |
| Stryker Corporation | $25.30 | 2023 | Alphavent |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.